Stocks and Finance

BioMimetic Therapeutics

BioMimetic Therapeutics 1/3/2012

19:42 : BioMimetic Therapeutics (BMTI) tanks in the post-trading session after ... - BioMimetic Therapeutics (BMTI) tanks in the post-trading session after the FDA says its proposed bone-graft device, Augment, wouldn't be approved without more information from previous studies. The company says it plans ...
Source : seekingalpha-com
actualidad BioMimetic Therapeutics -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts